Uoppgitt
ALCANCIA AS
Revenue 2024
NOK −3.7m
Operating profit
NOK −3.7m
Equity
NOK −15.1m
Incorporated
2019
Share capital
NOK 30,000
Roles
Regnskapsfører
Styrets lederSimen Thorsen
StyremedlemPer Knut Asphaug Bernhardt
Auditor
Auditor at related companies
None of the 3 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| BLEFJELL BYGG AS | HLO REVISJON & RÅDGIVNING AS | different |
| BLEFJELLTUNET AS | HLO REVISJON & RÅDGIVNING AS | different |
| HORTULAN ASSETS AS | HLO REVISJON & RÅDGIVNING AS | different |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| HORTULAN AS | 51.0% | 5100.000000 | 2025 |
| JANNE MERETE HJØRNEVIK THORSEN | 9.0% | 900.000000 | 2025 |
| CARL CHRISTIAN HERNES AASHEIM | 7.5% | 750.000000 | 2025 |
| PER KNUT ASPHAUG BERNHARDT | 7.5% | 750.000000 | 2025 |
| GISLE THORSEN | 4.0% | 400.000000 | 2025 |
| MARI HAVDAL SOLLIE | 4.0% | 400.000000 | 2025 |
| CELINE NICOLE HJØRNEVIK THORSEN | 3.2% | 325.000000 | 2025 |
| VICTORIA DANIELA THORSEN | 3.2% | 325.000000 | 2025 |
| RØYSEBERGET AS | 2.5% | 249.000000 | 2025 |
| MERETHE ARNØY | 2.4% | 238.000000 | 2025 |
| BRUNLANES VEKST AS | 2.4% | 238.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| NYKODE THERAPEUTICS ASA | Active | 0.1% | 200000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.